Gara Jalqabaatti › Kansaar Onnee Triple-Negative › Maine
Qorannoo klinikaalii Kansaar Onnee Triple-Negative Maine keessatti
Qorannoo 3 Kansaar Onnee Triple-Negative f Maine keessatti hirmaatuu jiru.
Takkalaa qorannoo (Ingiliffa)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- New England Cancer Specialists ( Site 0051), Westbrook
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06966700Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
- New England Cancer Specialists, Scarborough
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT05633654Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
- Eastern Maine Medical Center, Brewer
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Elb-2026 · NCT04468061Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.